Corrective Phases R...
Health Care: Drugs
Bentley Pharmaceuticals Inc. (BNT: NYSE)
$14.83 0.02 | 0.14%
07/22/08 - 04:05 PM ET
Ownership Summary data is not available for BNT.
Portfolios with BNT
- Portfolio NameUser Type
- Userbrihopper Portfolio 1
- Usersharonhsu Portfolio 1
- UserMikes dreams
- Userkmsica Portfolio 1
- UserSUPRATRADE SMALL CAP "...
- Usergiaomai11 Portfolio 1
- Userjrwannab Portfolio 1
- UserDave Bernstein Portfolio 1
- UserHAWAIIANEYES
- UserSUPRATRADE PHOENIX II
Latest BNT Headlines from TheStreet
- Feuerstein's Biotech-Stock Mailbag 04.19.08 | 09:04 am
- Monday's Health Winners & Losers 03.31.08 | 03:03 pm
- Teva to Buy Bentley Pharmaceuticals 03.31.08 | 09:03 am
- Thursday's Health Winners & Losers 12.27.07 | 03:12 pm
- Tuesday's Health Winners & Losers 10.23.07 | 04:10 pm
- Tuesday's Health Winners & Losers 08.06.07 | 09:08 pm
- Thursday's Health Winners & Losers 08.02.07 | 04:08 pm
- Monday's Health Winners & Losers 06.25.07 | 02:06 pm
- Friday's Health Winners & Losers 12.22.06 | 03:12 pm
- Health Stocks in Motion 11.21.05 | 04:11 pm
Press Releases for BNT
- Blue Note's Spinoff GeoVenCap Resumes Trading Today On The TSX Venture Exchange Under Symbol GOV - PR Newswire 03.26.12 | 09:03 am
- Blue Note Completes The Spinoff Of Its New Brunswick Properties To GeoVenCap - PR Newswire 03.22.12 | 10:03 am
Partner Headlines for BNT
